News Quantified

DRMA – dermata therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]

Dermata Therapeutics (NASDAQ:DRMA) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.

Form S-3 Dermata Therapeutics,

Form 8-K Dermata Therapeutics, For: Nov 17

Form 10-Q Dermata Therapeutics, For: Sep 30

Form 8-K Dermata Therapeutics, For: Nov 14

Form 8-K Dermata Therapeutics, For: Nov 07

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}